Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 920 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

TaiGen acquires global rights for Nemonoxacin

Following the transfer of rights, TaiGen will hold exclusive rights for development, manufacture, commercialization and sub-licensing of nemonoxacin. TaiGen originally licensed nemonoxacin product rights in ten Asian countries

Sanner on expansion spree in Asia

The company has expanded its plant in Kunshan, China and opened a new sales office in Indonesia. The facility of Kunshan makes standard products, including tubes and desiccant

Semler plans Asian expansion with ACA

ACA is a network of CROs (contract research organization) originating from Asia, which has established its presence in six Asian countries, pr.efytimes.com reported. ACA is said to make

Gilead HIV therapy trial meets end point

Integrase inhibitors interfere with HIV replication by blocking the ability of the virus to integrate into the genetic material of human cells. The Phase 3 Study, Study 145